Capvizr
THE DEAL, AT A GLANCE

ABLE Labs

From the announcement
01What it doesABLE Labs is to contribute improve human health by providing bio automated solutions.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by Big Pharma PoC this year < ENGLISH NEWS < 기사본문 - 더바이오From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedABLE Labs raised $12.1B Series A, announced 2026-08-31From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersABLE Labs is using a Series A financing round exceeding KRW 10 billion to support a lab automation push tied to bio automated solutions.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

ABLE Labs · Financing Record

Explore source-linked visual explanations for ABLE Labs. Unsupported claims are withheld while source review continues.

Record 11336 · Recorded date: 2026-08-31

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime